第一军医大学学报
第一軍醫大學學報
제일군의대학학보
JOURNAL OF FIRST MILITARY MEDICAL UNIVERSITY
2005年
2期
121-126
,共6页
欧阳石%孙莉莎%郭胜蓝%刘旭%徐江平
歐暘石%孫莉莎%郭勝藍%劉旭%徐江平
구양석%손리사%곽성람%류욱%서강평
知母总皂苷%beta样淀粉蛋白%Morris水迷宫测试%痴呆%自由基
知母總皂苷%beta樣澱粉蛋白%Morris水迷宮測試%癡呆%自由基
지모총조감%beta양정분단백%Morris수미궁측시%치태%자유기
timosaponins%amyloid β -peptide%Morris water maze%dementia%free radicals
目的建立大鼠β-淀粉样肽[Aβ(25-35)]诱导的痴呆模型,探讨知母总皂苷在阿耳茨海默病(AD)发病机制中的作用.方法SD大鼠60只,采用脑立体定位技术在大鼠单侧侧脑室一次性注射老化的Aβ(25-35)建立实验性AD模型.手术24 h后,大鼠经灌胃分别给予3种剂量的知母总皂苷和EGB761,模型组和空白组给予等剂量的蒸馏水,1次/1 d,连续14 d.在给予Aβ(25-35)后的第8天,应用Morris水迷宫法测定大鼠的学习记忆功能,造模后第14天断头取脑,测定脑组织超氧化物歧化酶(SOD)、丙二醛(MDA)和总抗氧化能力.结果与空白对照组相比,模型组大鼠空间学习记忆能力明显减弱,寻找平台潜伏期明显延长(P<0.01);脑组织SOD、总抗氧化能力明显降低(P<0.01),而MDA明显升高(P<0.05).与模型组比较,给予知母总皂苷治疗后的大鼠学习记忆功能障碍得到明显改善,潜伏期显著缩短(P<0.05),SOD活力显著提高(P<0.05),总抗氧化能力也显著增强(P<0.05),MDA水平明显降低(P<0.05).结论知母总皂苷可明显改善AD模型大鼠的学习记忆功能,同时可提高模型大鼠的抗过氧化能力,这有可能是其改善学习记忆的原因之一.
目的建立大鼠β-澱粉樣肽[Aβ(25-35)]誘導的癡呆模型,探討知母總皂苷在阿耳茨海默病(AD)髮病機製中的作用.方法SD大鼠60隻,採用腦立體定位技術在大鼠單側側腦室一次性註射老化的Aβ(25-35)建立實驗性AD模型.手術24 h後,大鼠經灌胃分彆給予3種劑量的知母總皂苷和EGB761,模型組和空白組給予等劑量的蒸餾水,1次/1 d,連續14 d.在給予Aβ(25-35)後的第8天,應用Morris水迷宮法測定大鼠的學習記憶功能,造模後第14天斷頭取腦,測定腦組織超氧化物歧化酶(SOD)、丙二醛(MDA)和總抗氧化能力.結果與空白對照組相比,模型組大鼠空間學習記憶能力明顯減弱,尋找平檯潛伏期明顯延長(P<0.01);腦組織SOD、總抗氧化能力明顯降低(P<0.01),而MDA明顯升高(P<0.05).與模型組比較,給予知母總皂苷治療後的大鼠學習記憶功能障礙得到明顯改善,潛伏期顯著縮短(P<0.05),SOD活力顯著提高(P<0.05),總抗氧化能力也顯著增彊(P<0.05),MDA水平明顯降低(P<0.05).結論知母總皂苷可明顯改善AD模型大鼠的學習記憶功能,同時可提高模型大鼠的抗過氧化能力,這有可能是其改善學習記憶的原因之一.
목적건립대서β-정분양태[Aβ(25-35)]유도적치태모형,탐토지모총조감재아이자해묵병(AD)발병궤제중적작용.방법SD대서60지,채용뇌입체정위기술재대서단측측뇌실일차성주사노화적Aβ(25-35)건립실험성AD모형.수술24 h후,대서경관위분별급여3충제량적지모총조감화EGB761,모형조화공백조급여등제량적증류수,1차/1 d,련속14 d.재급여Aβ(25-35)후적제8천,응용Morris수미궁법측정대서적학습기억공능,조모후제14천단두취뇌,측정뇌조직초양화물기화매(SOD)、병이철(MDA)화총항양화능력.결과여공백대조조상비,모형조대서공간학습기억능력명현감약,심조평태잠복기명현연장(P<0.01);뇌조직SOD、총항양화능력명현강저(P<0.01),이MDA명현승고(P<0.05).여모형조비교,급여지모총조감치료후적대서학습기억공능장애득도명현개선,잠복기현저축단(P<0.05),SOD활력현저제고(P<0.05),총항양화능력야현저증강(P<0.05),MDA수평명현강저(P<0.05).결론지모총조감가명현개선AD모형대서적학습기억공능,동시가제고모형대서적항과양화능력,저유가능시기개선학습기억적원인지일.
Objective To investigate the effects of timosaponins, one group of the two major components of A nemarrhean asphodeloides Bge, on the learning and memory capacities of rats with dementia induced by amyloid β-peptide (25-35) [Aβ(25-35)]. Methods Sixty SD rats were randomized into 6 groups (n=10) and except for those in the control group, all other rats were subjected to lateral cerebral ventriclar injection of aggregated Aβ (25-35) to prepare rat models of dementia. Twenty four hours after the injection, the rats received intragastric administration of timosaponins at 3 different doses (treatment group) or Ginkgo biloba extract EGB761 on a daily basis for 14 consecutive days. From postoperative days 8 to 14 after Aβ (25-35) injection, Morris water maze test was performed to evaluate the effects of Aβ (25-35) and the therapeutic agents timosaponins on the learning and memory capacity of the rats. On day 14, the level of malonaldehyde (MDA), superoxide dismutase (SOD) activity and total antioxidation capacity in the brain tissue of the rats were measured. Results Aβ (25-35) induced significant learning and memory impairment in the rats, which had lowered SOD activity and total antioxidation capacity (P<0.01) with elevated MDA level (P<0.05). Compared with the rats in dementia model group, those receiving timosaponin treatment at different doses all manifested alleviation of learning and memory impairment (P<0.05), with enhanced SOD activity (P<0.05) and total antioxidation capacity (P<0.01) and reduced MDA level (P<0.05) in the brain tissue. Conclusion Timosaponins can remarkably enhance the learning and memory capacities in rats with Aβ (25-35) -induced dementia, presumably in relation to their actions to promote the scavenging of the free radicals.